NRF2 activation by reversible KEAP1 binding induces the antioxidant response in primary neurons and astrocytes of a Huntington's disease mouse modelDaniele Moretti, Alberto Bresciani, Celia Dominquez et al.|Free Radical Biology and Medicine|2020Cited by 49
Combined Peptide and Small-Molecule Approach toward Nonacidic THIQ Inhibitors of the KEAP1/NRF2 InteractionJesus M. Ontoria, Steven J. Harper, Ilaria Biancofiore et al.|ACS Medicinal Chemistry Letters|2020Cited by 29
Optimization of linear and cyclic peptide inhibitors of KEAP1-NRF2 protein-protein interactionStefania Colarusso, Elisabetta Bianchi, Daniele De Simone et al.|Bioorganic & Medicinal Chemistry|2020Cited by 27
A21 Development of an Nrf2-KEAP1 protein-protein disruptor for proof of conceptAlberto Bresciani, Larry Park, Mauro Cerretani et al.|Journal of Neurology Neurosurgery & Psychiatry|2016Cited by 2